Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China

被引：228

作者：

Yu, Fei ^{[1
]}

Du, Lanying ^{[2
]}

Ojcius, David M. ^{[3
]}

Pan, Chungen ^{[4
]}

Jiang, Shibo ^{[2
,5
]}

机构：

[1] Hebei Agr Univ, Coll Life & Sci, Baoding, Peoples R China

[2] New York Blood Ctr, Lindsley Kimball Res Inst, New York, NY 10021 USA

[3] Univ Pacific, Sch Dent, Dept Biomed Sci, San Francisco, CA 94115 USA

[4] Guangdong Haid Grp Co Ltd, Haid Res Inst, Guangdong Haid Inst Anim Husb & Vet, Guangzhou, Peoples R China

[5] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China

来源：

MICROBES AND INFECTION | 2020年 / 22卷 / 02期

关键词：

2019-nCoV; Diagnosis; Preventive; Therapeutic; EAST RESPIRATORY SYNDROME; RECEPTOR-BINDING DOMAIN; HUMAN MONOCLONAL-ANTIBODIES; SPIKE PROTEIN; SARS-COV; MERS-COV; NEUTRALIZING ANTIBODY; POSTEXPOSURE EFFICACY; CROSS-NEUTRALIZATION; FUNCTIONAL RECEPTOR;

D O I：

10.1016/j.micinf.2020.01.003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

On 10 January 2020, a new coronavirus causing a pneumonia outbreak in Wuhan City in central China was denoted as 2019-nCoV by the World Health Organization (WHO). As of 24 January 2020, there were 887 confirmed cases of 2019-nCoV infection, including 26 deaths, reported in China and other countries. Therefore, combating this new virus and stopping the epidemic is a matter of urgency. Here, we focus on advances in research and development of fast diagnosis methods, as well as potential prophylactics and therapeutics to prevent or treat 2019-nCoV infection. (C) 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

引用

页码：74 / 79

页数：6

共 72 条

[21] Evaluation and Clinical Validation of Two Field-Deployable Reverse Transcription-Insulated Isothermal PCR Assays for the Detection of the Middle East Respiratory Syndrome-Coronavirus
Go, Yun Young
Kim, Yeon-Sook
Cheon, Shinhye
Nam, Sangwoo
Ku, Keun Bon
Kim, Meehyein
Cho, Nam Hyuk
Park, Hyun
Lee, Pei-Yu Alison
Lin, Yu-Chun
Tsai, Yun-Long
Wang, Hwa-Tang Thomas
Balasuriya, Udeni B. R.
[J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06) : 817 - 827
[22] Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections: A Systematic Review
Gross, Alan E.
Bryson, Michelle L.
[J]. ANNALS OF PHARMACOTHERAPY, 2015, 49 (10) : 1125 - 1135
[23] Development of Dual TaqMan Based One-Step rRT-PCR Assay Panel for Rapid and Accurate Diagnostic Test of MERS-CoV: A Novel Human Coronavirus, Ahead of Hajj Pilgrimage
Hashemzadeh, Mohammad Sadegh
Rasouli, Rahimeh
Zahraei, Bentolhoda
Izadi, Morteza
Tat, Mahdi
Saadat, Seyed Hassan
Najarasl, Mohammad
Nejad, Behzad Khansari
Dorostkar, Ruhollah
[J]. IRANIAN RED CRESCENT MEDICAL JOURNAL, 2016, 18 (11)
[24] Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein
He, Yuxian
Li, Jingjing
Li, Wenhui
Lustigman, Sara
Farzan, Michael
Jiang, Shibo
[J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (10) : 6085 - 6092
[25] Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies
He, YX
Lu, H
Siddiqui, P
Zhou, YS
Jiang, SB
[J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (08) : 4908 - 4915
[26] Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: Importance for designing SARS vaccines
He, YX
Zhu, QY
Liu, SW
Zhou, YS
Yang, BA
Li, JM
Jiang, SB
[J]. VIROLOGY, 2005, 334 (01) : 74 - 82
[27] Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
He, YX
Zhou, YS
Siddiqui, P
Jiang, SB
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 325 (02) : 445 - 452
[28] Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
He, YX
Zhou, YS
Liu, SW
Kou, ZH
Li, WH
Farzan, M
Jiang, SB
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (02) : 773 - 781
[29] A Rapid and Specific Assay for the Detection of MERS-CoV
Huang, Pei
Wang, Hualei
Cao, Zengguo
Jin, Hongli
Chi, Hang
Zhao, Jincun
Yu, Beibei
Yan, Feihu
Hu, Xingxing
Wu, Fangfang
Jiao, Cuicui
Hou, Pengfei
Xu, Shengnan
Zhao, Yongkun
Feng, Na
Wang, Jianzhong
Sun, Weiyang
Wang, Tiecheng
Gao, Yuwei
Yang, Songtao
Xia, Xianzhu
[J]. FRONTIERS IN MICROBIOLOGY, 2018, 9
[30] HIV-1 INHIBITION BY A PEPTIDE
JIANG, SB
LIN, K
STRICK, N
NEURATH, AR
[J]. NATURE, 1993, 365 (6442) : 113 - 113

← 1 2 3 4 5 6 7 8 →